The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF

21 January 2025 (16:07 - 16:30)
Organised by: Logo
Seminar Presentation Part of: The cardiometabolic syndrome and extracardiac drug effects beneficial to the heart Drugs, Drug Targets Delegate Premium access HFA Winter Research Meeting on Translational Heart Failure 2025 Heart Failure Association (HFA)